Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06783504 · ClinicalTrials.gov registry record · NA
Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2
A NA study, sponsored by Indiana University.
- Not yet
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06783504 is a NA study that has not yet begun recruiting, run by Indiana University. The registered enrollment target is 60 participants.
The verdict
NCT06783504, a NA study, has not yet begun recruiting, sponsored by Indiana University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if we can stimulate the vagus nerve. The vagus nerve is a largely internal nerve that controls many bodily functions, including stomach function. We hope that electrically stimulating the nerve around the external ear will also stimulate the internal vagus nerve. If it does, then we hope that this will help our treatment of patients with nausea and vomiting and disordered stomach function.
Interventions
- DEVICE Sham percutaneous electrical nerve field stimulation
- DEVICE PERCUTANEOUS ELECTRICAL FIELD NERVE STIMULATION
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2027-02-10 |
| Est. Completion | 2029-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06783504
The ClinicalTrials.gov registry entry for NCT06783504 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham percutaneous electrical nerve field stimulation is the first listed.
NCT06783504 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06783504 about?
NCT06783504 is a clinical study titled "Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2". The purpose of this study is to find out if we can stimulate the vagus nerve. The vagus nerve is a largely internal nerve that controls many bodily functions, including stomach function. We hope that electrically stimulating the nerve around the external ear will also stimulate the internal vagus ne...
What is the current status of trial NCT06783504?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2027-02-10. Estimated completion is 2029-08.
What interventions are being tested in trial NCT06783504?
The interventions under investigation include: Sham percutaneous electrical nerve field stimulation (DEVICE), PERCUTANEOUS ELECTRICAL FIELD NERVE STIMULATION (DEVICE).
Who is sponsoring clinical trial NCT06783504?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.